SCHEMBL3595152

SCHEMBL3595152

NC(=O)c1ccc(-c2cc(-c3nnn[nH]3)c(-c3ccc(C(N)=O)cc3)s2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRF1 P14222 3/20 0.42
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
MKNK1 Q9BUB5 4/20 0.37
MKNK2 Q9HBH9 4/20 0.37
MAP3K8 P41279 2/20 0.37
STK17B O94768 1/20 0.37
STK17A Q9UEE5 1/20 0.37
PTGS1 P23219 1/20 0.36
CHEK2 O96017 3/20 0.35
CHEK1 O14757 2/20 0.35
MAP2K4 P45985 2/20 0.34
MAPK1 P28482 1/20 0.34
MAPKAPK2 P49137 1/20 0.34
MAPKAPK3 Q16644 1/20 0.34
MAPK6 Q16659 1/20 0.34
MAPKAPK5 Q8IW41 1/20 0.34
GPR52 Q9Y2T5 1/20 0.34
CCNC P24863 1/20 0.34
CDK8 P49336 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3607451 0.88 ESR1 (0.41) ESR1ESR2MAP2K4MAPK1MAPKAPK3
SCHEMBL3596461 0.86 HSD17B1 (0.41) PRF1MAP3K8STK17ACHEK2CHEK1
SCHEMBL3604357 0.82 ESR1 (0.61) ESR1ESR2
SCHEMBL3601024 0.80 MAPK14 (0.42) ESR1ESR2PTGS1
SCHEMBL16062588 0.80 ESR1 (0.41) ESR1ESR2MAPK1
SCHEMBL751010 0.79 MKNK1 (0.42) MKNK1MKNK2CHEK2MAP2K4MAPK1
SCHEMBL3612213 0.78 CDC7 (0.40) ESR1ESR2
SCHEMBL3606907 0.78 HDAC1 (0.44) MAP2K4MAPK1MAPKAPK3MAPK6
SCHEMBL4436864 0.77 MKNK1 (0.47) MKNK1MKNK2CHEK2MAP2K4
SCHEMBL4025859 0.76 MKNK1 (0.44) MKNK1MKNK2CHEK2CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835476-B2 Synthesis of novel antimicrobials WU FAN (CA) 2014-09-16 US disclosed
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials WU FAN 2010-03-25 US disclosed
WO-2006092059-A1 DESIGN AND SYNTHESIS OF NOVEL ANTIMICROBIALS WU FAN (CA) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials MLX, LPXN, TPX2 PRF1 2604/4885ESR1 1779/4885ESR2 2227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.